A clinical trial for Ebola treatments targeting the current outbreak in the Democratic Republic of Congo has commenced, enrolling its first patient, WHO announced.

The Bundibugyo strain has no approved vaccine or targeted treatment, leaving supportive care as the primary option.

L'Organizzazione mondiale della sanità avvia il reclutamento dei pazienti per il trial PARTNERS nella Repubblica Democratica del Congo. In attesa di un vaccino, saranno valutati…